Cargando…

Can we predict when to start renal replacement therapy in patients with chronic kidney disease using 6 months of clinical data?

PURPOSE: We aimed to develop a model of chronic kidney disease (CKD) progression for predicting the probability and time to progression from various CKD stages to renal replacement therapy (RRT), using 6 months of clinical data variables routinely measured at healthcare centers. METHODS: Data were d...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Min-Jeong, Park, Joo-Han, Moon, Yeo Rae, Jo, Soo-Yeon, Yoon, Dukyong, Park, Rae Woong, Jeong, Jong Cheol, Park, Inwhee, Shin, Gyu-Tae, Kim, Heungsoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171856/
https://www.ncbi.nlm.nih.gov/pubmed/30286208
http://dx.doi.org/10.1371/journal.pone.0204586
_version_ 1783360837125144576
author Lee, Min-Jeong
Park, Joo-Han
Moon, Yeo Rae
Jo, Soo-Yeon
Yoon, Dukyong
Park, Rae Woong
Jeong, Jong Cheol
Park, Inwhee
Shin, Gyu-Tae
Kim, Heungsoo
author_facet Lee, Min-Jeong
Park, Joo-Han
Moon, Yeo Rae
Jo, Soo-Yeon
Yoon, Dukyong
Park, Rae Woong
Jeong, Jong Cheol
Park, Inwhee
Shin, Gyu-Tae
Kim, Heungsoo
author_sort Lee, Min-Jeong
collection PubMed
description PURPOSE: We aimed to develop a model of chronic kidney disease (CKD) progression for predicting the probability and time to progression from various CKD stages to renal replacement therapy (RRT), using 6 months of clinical data variables routinely measured at healthcare centers. METHODS: Data were derived from the electronic medical records of Ajou University Hospital, Suwon, South Korea from October 1997 to September 2012. We included patients who were diagnosed with CKD (estimated glomerular filtration rate [eGFR] < 60 mL·min(–1)·1.73 m(–2) for ≥ 3 months) and followed up for at least 6 months. The study population was randomly divided into training and test sets. RESULTS: We identified 4,509 patients who met reasonable diagnostic criteria. Patients were randomly divided into 2 groups, and after excluding patients with missing data, the training and test sets included 1,625 and 1,618 patients, respectively. The integral mean was the most powerful explanatory (R(2) = 0.404) variable among the 8 modified values. Ten variables (age, sex, diabetes mellitus[DM], polycystic kidney disease[PKD], serum albumin, serum hemoglobin, serum phosphorus, serum potassium, eGFR (calculated by Chronic Kidney Disease Epidemiology Collaboration [CKD-EPI]), and urinary protein) were included in the final risk prediction model for CKD stage 3 (R(2) = 0.330). Ten variables (age, sex, DM, GN, PKD, serum hemoglobin, serum blood urea nitrogen[BUN], serum calcium, eGFR(calculated by Modification of Diet in Renal Disease[MDRD]), and urinary protein) were included in the final risk prediction model for CKD stage 4 (R(2) = 0.386). Four variables (serum hemoglobin, serum BUN, eGFR(calculated by MDRD) and urinary protein) were included in the final risk prediction model for CKD stage 5 (R(2) = 0.321). CONCLUSION: We created a prediction model according to CKD stages by using integral means. Based on the results of the Brier score (BS) and Harrel’s C statistics, we consider that our model has significant explanatory power to predict the probability and interval time to the initiation of RRT.
format Online
Article
Text
id pubmed-6171856
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-61718562018-10-19 Can we predict when to start renal replacement therapy in patients with chronic kidney disease using 6 months of clinical data? Lee, Min-Jeong Park, Joo-Han Moon, Yeo Rae Jo, Soo-Yeon Yoon, Dukyong Park, Rae Woong Jeong, Jong Cheol Park, Inwhee Shin, Gyu-Tae Kim, Heungsoo PLoS One Research Article PURPOSE: We aimed to develop a model of chronic kidney disease (CKD) progression for predicting the probability and time to progression from various CKD stages to renal replacement therapy (RRT), using 6 months of clinical data variables routinely measured at healthcare centers. METHODS: Data were derived from the electronic medical records of Ajou University Hospital, Suwon, South Korea from October 1997 to September 2012. We included patients who were diagnosed with CKD (estimated glomerular filtration rate [eGFR] < 60 mL·min(–1)·1.73 m(–2) for ≥ 3 months) and followed up for at least 6 months. The study population was randomly divided into training and test sets. RESULTS: We identified 4,509 patients who met reasonable diagnostic criteria. Patients were randomly divided into 2 groups, and after excluding patients with missing data, the training and test sets included 1,625 and 1,618 patients, respectively. The integral mean was the most powerful explanatory (R(2) = 0.404) variable among the 8 modified values. Ten variables (age, sex, diabetes mellitus[DM], polycystic kidney disease[PKD], serum albumin, serum hemoglobin, serum phosphorus, serum potassium, eGFR (calculated by Chronic Kidney Disease Epidemiology Collaboration [CKD-EPI]), and urinary protein) were included in the final risk prediction model for CKD stage 3 (R(2) = 0.330). Ten variables (age, sex, DM, GN, PKD, serum hemoglobin, serum blood urea nitrogen[BUN], serum calcium, eGFR(calculated by Modification of Diet in Renal Disease[MDRD]), and urinary protein) were included in the final risk prediction model for CKD stage 4 (R(2) = 0.386). Four variables (serum hemoglobin, serum BUN, eGFR(calculated by MDRD) and urinary protein) were included in the final risk prediction model for CKD stage 5 (R(2) = 0.321). CONCLUSION: We created a prediction model according to CKD stages by using integral means. Based on the results of the Brier score (BS) and Harrel’s C statistics, we consider that our model has significant explanatory power to predict the probability and interval time to the initiation of RRT. Public Library of Science 2018-10-04 /pmc/articles/PMC6171856/ /pubmed/30286208 http://dx.doi.org/10.1371/journal.pone.0204586 Text en © 2018 Lee et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Lee, Min-Jeong
Park, Joo-Han
Moon, Yeo Rae
Jo, Soo-Yeon
Yoon, Dukyong
Park, Rae Woong
Jeong, Jong Cheol
Park, Inwhee
Shin, Gyu-Tae
Kim, Heungsoo
Can we predict when to start renal replacement therapy in patients with chronic kidney disease using 6 months of clinical data?
title Can we predict when to start renal replacement therapy in patients with chronic kidney disease using 6 months of clinical data?
title_full Can we predict when to start renal replacement therapy in patients with chronic kidney disease using 6 months of clinical data?
title_fullStr Can we predict when to start renal replacement therapy in patients with chronic kidney disease using 6 months of clinical data?
title_full_unstemmed Can we predict when to start renal replacement therapy in patients with chronic kidney disease using 6 months of clinical data?
title_short Can we predict when to start renal replacement therapy in patients with chronic kidney disease using 6 months of clinical data?
title_sort can we predict when to start renal replacement therapy in patients with chronic kidney disease using 6 months of clinical data?
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171856/
https://www.ncbi.nlm.nih.gov/pubmed/30286208
http://dx.doi.org/10.1371/journal.pone.0204586
work_keys_str_mv AT leeminjeong canwepredictwhentostartrenalreplacementtherapyinpatientswithchronickidneydiseaseusing6monthsofclinicaldata
AT parkjoohan canwepredictwhentostartrenalreplacementtherapyinpatientswithchronickidneydiseaseusing6monthsofclinicaldata
AT moonyeorae canwepredictwhentostartrenalreplacementtherapyinpatientswithchronickidneydiseaseusing6monthsofclinicaldata
AT josooyeon canwepredictwhentostartrenalreplacementtherapyinpatientswithchronickidneydiseaseusing6monthsofclinicaldata
AT yoondukyong canwepredictwhentostartrenalreplacementtherapyinpatientswithchronickidneydiseaseusing6monthsofclinicaldata
AT parkraewoong canwepredictwhentostartrenalreplacementtherapyinpatientswithchronickidneydiseaseusing6monthsofclinicaldata
AT jeongjongcheol canwepredictwhentostartrenalreplacementtherapyinpatientswithchronickidneydiseaseusing6monthsofclinicaldata
AT parkinwhee canwepredictwhentostartrenalreplacementtherapyinpatientswithchronickidneydiseaseusing6monthsofclinicaldata
AT shingyutae canwepredictwhentostartrenalreplacementtherapyinpatientswithchronickidneydiseaseusing6monthsofclinicaldata
AT kimheungsoo canwepredictwhentostartrenalreplacementtherapyinpatientswithchronickidneydiseaseusing6monthsofclinicaldata